Drugs / PF-00446687
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00479570 | Jun 2007 → Feb 2008 | sexual disorder | Pfizer | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00862888 Comparator | Jul 2007 → Feb 2008 | erectile dysfunction | Pfizer | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-00446687 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00479570 ↗ |
| Action | Activate | “Melanocortin receptor 4 agonist” CHEMBL1090488 ↗ |
| Modality | Small molecule | — CHEMBL1090488 ↗ |
| Route | Oral | “Single 200mg dose as an oral solution” NCT00862888 ↗ |
| Target | MC4R | “Melanocortin receptor 4 agonist” CHEMBL1090488 ↗ |